Welcome to the lung channel. Explore the latest updates in lung cancer, including expert interviews from major international congresses and news by subtype.

There are 2 main types of lung cancer – non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC accounts for ~85% of cases and includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma.

Although traditional treatment options for patients with lung cancer including chemotherapy, radiotherapy and surgery are still widely used, exciting advances have been made in the field of lung cancer in recent years. These include the identification of molecular aberrations in key signal transduction pathways, and the subsequent development of novel targeted therapies for patients with NSCLC, as well as the introduction of immunotherapies, including immune checkpoint inhibitors.

As well as novel treatment options, there are many ongoing strategies to help reduce the incidence of lung cancer, including screening and smoking cessation campaigns.

Lung Cancer

The Lung Cancer Channel on VJOncology is supported by Takeda.
This supporter has no influence over the production of the content.


If you are interested in becoming a supporter of The Lung Channel, please contact us

Lung Cancer

Welcome to the lung channel. Explore the latest updates in lung cancer, including expert interviews from major international congresses and news by subtype.

There are 2 main types of lung cancer – non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC accounts for ~85% of cases and includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma.

Although traditional treatment options for patients with lung cancer including chemotherapy, radiotherapy and surgery are still widely used, exciting advances have been made in the field of lung cancer in recent years. These include the identification of molecular aberrations in key signal transduction pathways, and the subsequent development of novel targeted therapies for patients with NSCLC, as well as the introduction of immunotherapies, including immune checkpoint inhibitors.

As well as novel treatment options, there are many ongoing strategies to help reduce the incidence of lung cancer, including screening and smoking cessation campaigns.

View all videos
The Lung Cancer Channel on VJOncology is supported by Takeda.
This supporter has no influence over the production of the content.


If you are interested in becoming a supporter of The Lung Channel, please contact us

Lung Cancer Videos by Conference


If you are interested in becoming a supporter of The Lung Channel, please contact us

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter